Evidenced by the move to measure and reimburse providers based on the quality, as opposed to the quantity, of care delivered, the healthcare industry is shifting from a fee-for-service to an outcomes or value-based model.

SQI Diagnostics Inc. announced two new product launches within the imaware family of at-home tests by its partner, Microdrop.

To prepare for radiological and nuclear emergencies, the U.S. Department of Health and Human Services (HSS) announced it will work with Argentum Medical LLC to repurpose the company’s commercial Silverlon technology for radiation injuries of the skin.

Abbott announced U.S. Food and Drug Administration approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib).

Intouch Solutions’ Sean Hartigan and Heartbeat’s David Sakadelis say their pharma clients are skittish about the use of chatbots and AI, with an understanding of these technologies more influenced by the grim future of Skynet in the “Terminator” movie franchise rather than the reality of where AI is right now.

  Proprietary Research Panel Gives Health Tech Marketers Rapid Access to C-Suite Executives for First-Hand Decision Making Insights   PHILADELPHIA, Nov. 14, 2018 /PRNewswire/ — VIVO Agency, the healthcare marketing […]

Robert Miller, CEO of Honeycomb Health, was tapped to be a keynote speaker at the ProcureCon Pharma Conference on October 22nd-23rd, 2018.

PureTech Health plc entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to advance PureTech’s milk-derived exosome platform technology for the oral administration of Roche’s antisense oligonucleotide platform.

ISPOR, the professional society for health economics and outcomes research, announced that registration is open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.”